文献速递食管胃疾病与幽门螺杆菌消化道肿瘤与早癌

RNF128异构体调控Barrett食管细胞中突变p53的稳定性

Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells.
PubMed 文献 · Gastroenterology · 2019-11-09

该研究分析54例Barrett食管(BE)样本及166例RT-PCR和100例组织芯片,发现BE进展为高级别异型增生或食管腺癌时RNF128 Iso1表达升高、Iso2降低,Iso1糖基化后泛素连接酶活性低而稳定突变p53,Iso2则促进突变p53降解;辛伐他汀可降解Iso1并减缓小鼠移植瘤生长。

要点

  • BE进展中RNF128 Iso1升高、Iso2降低,共同稳定突变p53。
  • Iso1糖基化后泛素连接酶活性低,敲低可促突变p53降解。
  • 辛伐他汀降解Iso1并减缓EAC移植瘤生长。

核心结论

  • BE细胞中RNF128 Iso2减少导致突变p53水平升高,而Iso1增加进一步促进突变p53稳定。

研究设计与样本

  • 获取1992至2015年间54例高级别异型增生或EAC患者的BE样本进行RNA测序及异构体特异性分析。
  • 对166例样本行逆转录聚合酶链反应分析,对含100例高级别异型增生或EAC及正常食管鳞状黏膜对照的组织芯片行免疫组化分析。
  • 在BE细胞中转染质粒表达蛋白或用小干扰RNA敲低,行免疫印迹、免疫沉淀和泛素连接酶试验。
  • 将OE-33细胞来源的EAC移植瘤裸鼠腹腔注射辛伐他汀,监测肿瘤生长并免疫印迹检测RNF128、p53和乙酰化p53水平。

主要发现

  • BE进展为高级别异型增生或EAC伴随编码黏蛋白及促进炎症、ATM和DNA损伤应答激活的mRNA表达变化。
  • 组织从BE进展为高级别异型增生再到EAC时,RNF128 Iso1的mRNA表达增加而Iso2表达减少。
  • 干扰素γ孵育BE细胞增加Iso1表达并减少Iso2表达。
  • Iso1高度糖基化,对p53的泛素连接酶活性有限,导致p53稳定。
  • 敲低Iso1导致突变型p53降解并降低克隆存活;Iso2是强效连接酶,降低BE细胞中突变型p53水平。

临床怎么用

  • RNF128异构体可能作为BE进展为高级别异型增生或EAC的监测标志物。
  • 辛伐他汀降解RNF128 Iso1并减缓EAC移植瘤生长,提示其潜在干预价值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Barrett's esophagus (BE) can progress to dysplasia and esophageal adenocarcinoma (EAC), accompanied by mutations in TP53 that increase the stability of its product, p53. We analyzed BE tissues for messenger RNAs (mRNAs) that associate with BE progression and identified one that affects the stabilization of p53. METHODS: We obtained 54 BE samples collected from patients with high-grade dysplasia (HGD) or esophageal adenocarcinoma (EAC), from 1992 through 2015, and performed RNA sequence analyses, including isoform-specific analyses. We performed reverse-transcription polymerase chain reaction analyses of 166 samples and immunohistochemical analyses of tissue microarrays that contained BE tissues from 100 patients with HGD or EAC and normal esophageal squamous mucosa (controls). Proteins were expressed from transfected plasmids or knocked down with small interfering RNAs in BE cells and analyzed by immunoblots and in immunoprecipitation and ubiquitin ligase assays. Athymic nude mice bearing EAC xenograft tumors (grown from OE-33 cells) were given intraperitoneal injections of simvastatin; tumor growth was monitored and tumors were collected and analyzed by immunoblotting for levels of RNF128, p53, and acetylated p53. RESULTS: Progression of BE to HGD or EAC associated with changes in expression of mRNAs that encoded mucins and promoted inflammation and activation of ATM and the DNA damage response. As tissues progressed from BE to HGD to EAC, they increased expression of mRNAs encoding isoform 1 of RNF128 (Iso1) and decreased expression of Iso2 of RNF128. RNF128 is an E3 ubiquitin ligase that targets p53 for degradation. Incubation of BE cells with interferon gamma caused them to increase expression of Iso1 and reduce expression of Iso2. Iso1 was heavily glycosylated with limited ubiquitin ligase activity for p53, resulting in p53 stabilization. Knockdown of Iso1 in BE and EAC cells led to degradation of the mutant form of p53 and reduced clonogenic survival. In contrast, Iso2 was a potent ligase that reduced levels of the mutant form of p53 in BE cells. In BE cells, Iso2 was hypoglycosylated and degraded, via ATM and GSK3β-mediated phosphorylation and activation of the beta-TrCP1-containing SCF ubiquitin ligase complex. Simvastatin, which degrades the mutant form of p53, also degraded RNF128 Iso1 protein in BE cells and slowed growth of EAC xenograft tumors in mice. CONCLUSIONS: We found that isoform 2 of RNF128 is decreased in BE cells, resulting in increased levels of mutant p53, whereas isoform 1 of RNF128 is increased in BE cells, further promoting the stabilization of mutant p53.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Ray D, Ray P, Ferrer-Torres D, et al. Isoforms of RNF128 Regulate the Stability of Mutant P53 in Barrett's Esophageal Cells. Gastroenterology. 2019. PMID: 31715145. doi:10.1053/j.gastro.2019.10.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。